Riverbridge Partners LLC Has $9.06 Million Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Riverbridge Partners LLC trimmed its position in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 11.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 390,774 shares of the company's stock after selling 52,295 shares during the quarter. Riverbridge Partners LLC owned approximately 1.61% of OrthoPediatrics worth $9,058,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP boosted its holdings in shares of OrthoPediatrics by 16.2% in the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company's stock worth $23,944,000 after buying an additional 122,846 shares during the period. Harbor Capital Advisors Inc. boosted its holdings in shares of OrthoPediatrics by 268.1% in the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company's stock worth $6,692,000 after buying an additional 179,803 shares during the period. Barclays PLC boosted its holdings in shares of OrthoPediatrics by 319.3% in the third quarter. Barclays PLC now owns 25,298 shares of the company's stock worth $686,000 after buying an additional 19,264 shares during the period. Geode Capital Management LLC boosted its holdings in shares of OrthoPediatrics by 2.1% in the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company's stock worth $10,615,000 after buying an additional 7,972 shares during the period. Finally, International Assets Investment Management LLC lifted its position in shares of OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after purchasing an additional 966 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently issued reports on KIDS. Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a research report on Wednesday, December 18th. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price target on shares of OrthoPediatrics in a research report on Tuesday, January 14th.

OrthoPediatrics Stock Up 0.1 %

Shares of NASDAQ KIDS traded up $0.04 during mid-day trading on Thursday, reaching $27.16. The company had a trading volume of 44,238 shares, compared to its average volume of 313,802. The company has a market capitalization of $657.82 million, a price-to-earnings ratio of -22.08 and a beta of 1.14. The stock has a fifty day moving average of $24.15 and a two-hundred day moving average of $27.28. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics Corp. has a 12-month low of $21.02 and a 12-month high of $35.99.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.